| Profile | GDS5822 / ILMN_1216021 |
| Title | Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model |
| Organism | Mus musculus |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1276599 | PDAC Late Ablation Control 1 | 53.3 | 71 |
| GSM1276600 | PDAC Late Ablation Control 2 | 26.3 | 54 |
| GSM1276601 | PDAC Late Ablation Control 3 | 20.2 | 50 |
| GSM1276602 | PDAC Late Ablation 1 | 76 | 74 |
| GSM1276603 | PDAC Late Ablation 2 | 50 | 69 |
| GSM1276604 | PDAC Late Ablation 3 | 48.5 | 67 |
| GSM1303940 | PDAC Late Ablation_anti-CTLA4 1 | 48.7 | 70 |
| GSM1303941 | PDAC Late Ablation_anti-CTLA4 2 | 48.9 | 66 |
| GSM1303942 | PDAC Late Ablation_anti-CTLA4 3 | 91.2 | 73 |